• Centralized Medical Billing
• Insurance Credentialing
• Analysis of Fee Structure
• Reimbursement Consulting
• Staff Training
• On–going Site visits
• Telephone Support
• Education
|
11/08/2005
Optometric Medicine takes off in
South Texas.
Read More
06/15/2005
"Beyond Lasik" Newsweek story.
Read More
05/11/2005
Crystalens by Eyeonics Can be
Balanced Billed to Medicare Patients.
Read More |
|
Proposed Courses and Speakers are included. Suggestions are shown in italics. Lecture Sponsors can modify course outlines, speaker selections, meeting locations, dates and times. Final courses with locations and dates will be posted 30 days in advance.
TOPIC: Update on Diagnosis and Treatment of Retinal Pathology
The discussion will provide an overview on how certain pharmaceuticals are being used to treat and manage retinal pathology. It will include a discussion on what to refer, what not to refer.
LOCATIONS
SAN ANTONIO: October 2006, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D. and James E. Speights, M.D.
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: Potential speakers Dr. B_______, Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: Potential speakers _________,M.D., Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
TOPIC: Dry Eye
The discussion will provide an overview on diagnosis and treatment of dry eye. How certain pharmaceuticals, surgical techniques and punctal plugs are being used to treat and manage. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: January 2007, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Allerghan-Restasis, Alcon-Systane, B&L Alrex)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Allerghan-Restasis, Alcon-Systane, B&L Alrex)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: (Potential speakers Derek Cunningham, O.D. )
SPONSORS/REPS: (Potential Sponsors: Allerghan-Restasis, Alcon-Systane, B&L Alrex)
TOPIC: Allergy
The discussion will cover current theories on the origin of certain allergies and how current pharmaceuticals participate in their treatment. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: February 2007, Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
TOPIC: A Comprehensive Discussion of Red Eye
The discussion will cover trama, diagnosis and current treatment protocols. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: March 2007, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
TOPIC: Using IOLs to Treat Refractive Error
The discussion will include determining candidacy, how to explain to patients the features and benefits of aphakic and psuedophakic IOLs and a comparison of the currenly available IOLs. Pre-op management, post-op management and handling complications. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: May 2007, Limit attendance to ___________
SPEAKERS: Robert Snip, M.D., Mike Ference, III, M.D., Kenneth Maverick, M.D.
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
TOPIC: Update on Diagnosis and Treatment of Retinal Pathology
The discussion will provide an overview on how certain pharmaceuticals are being used to treat and manage retinal pathology. It will include a discussion on what to refer, what not to refer. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: September 2007, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D. and James E. Speights, M.D.
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
TOPIC: Update on Diagnosis and Treatment of Glaucoma
The discussion will provide an overview on how current technology can be used to detect early warning signs, how certain pharmaceuticals are being used to treat and manage the disease and how patient compliance is a factor in managing treatment. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: October 2007, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
TOPIC: Glaucoma Wet Lab
Various equipment manufacturers will be invited to bring instruments and explain their features and benefits. Attendees will be allowed the opportunity to work with the instruments. It will include a brief discussion on coordinating insurance billing with standard treatment protocols. (Instructors may include optometrists that already own an instrument being used in the wet lab)
LOCATIONS
SAN ANTONIO: January 2008, Limit attendance to ___________
INSTRUCTORS: (4) ___________, __________, __________, __________
SPONSORS/REPS: (Potential Sponsors: HRT, OCT, GDX, Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
AUSTIN: ____________ Limit attendance to ___________
INSTRUCTORS: (4) ___________, __________, __________, __________
SPONSORS/REPS: (Potential Sponsors: HRT, OCT, GDX, Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
DFW Metroplex: ____________ Limit attendance to ___________
INSTRUCTORS: (4) ___________, __________, __________, __________
SPONSORS/REPS: (Potential Sponsors: HRT, OCT, GDX, Kowa, Humphey, Nikon, Allergan–Alphagan/Lumigan, Alcon–Azopt, Merk–Cosopt, Trusopt)
TOPIC: Update on Diagnosis and Treatment of Ocular Trauma
The discussion will provide an overview on how diagnosis and treatment and how certain pharmaceuticals are being used. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: February 2008, Limit attendance to ___________
SPEAKERS: ___________
SPONSORS/REPS: (Potential Sponsors: Allergan – Acular, Novartis – Valsurtan)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan – Acular, Novartis – Valsurtan)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan – Acular, Novartis – Valsurtan)
TOPIC: Allergy
The discussion will cover current theories on the origin of certain allergies and how current pharmaceuticals participate in their treatment. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: March 2008, Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Zaditor, Alcon–Patanol, Inspire–Elostat, B&L–Alrex)
TOPIC: Using IOLs to Treat Refractive Error
The discussion will include determining candidacy, how to explain to patients the features and benefits of aphakic and psuedophakic IOLs and a comparison of the currenly available IOLs. Pre-op management, post-op management and handling complications. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: May 2008, Limit attendance to ___________
SPEAKERS: Robert Snip, M.D., Mike Ference, III, M.D., Kenneth Maverick, M.D.
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Starr, Allergan, Alcon, Eyeonics, Surgical Equipment Vendors)
TOPIC: A Comprehensive Discussion of Chronic Eye Inflammation
The discussion will cover the causes of eye inflammation, diagnosis and current treatment protocols. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: August 2008, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D.
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Allergan–Acular/Zymar, Alcon–Vigamox, B&L–Zylet/Lotemax, Norartis–Voltaren)
TOPIC: Post IOL Retina Care
The discussion will provide an overview on how cataract extraction and IOL implantation can affect the retina. What to look for, how treat, what to refer, what not to refer. It will include an in depth presentation of coordinating insurance billing with standard treatment protocols.
LOCATIONS
SAN ANTONIO: October 2008, Limit attendance to ___________
SPEAKERS: Derek Cunningham, O.D. and James E. Speights, M.D.
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
AUSTIN: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
DFW Metroplex: ____________ Limit attendance to ___________
SPEAKERS: ______________
SPONSORS/REPS: (Potential Sponsors: Novartis–Visudyne, Pfizer-Macugen, Alcon-Retaane, B&L-Vitrasert)
|
|
